In this interview with SmartTRAK, Hy2Care CEO Leo Smit discusses the company's innovative technology. Hy2Care, a Dutch spin-off from the University of Twente, is developing a new hydrogel platform to address focal cartilage defects. Smit explains their "joint-mimicking" hydrogel, which is applied arthroscopically as a liquid, enzymatically cross-links in place within one minute, and bonds strongly to surrounding tissue. The product could represent a new generation of acellular, off-the-shelf scaffolds that aim to close this gap by offering a simpler procedure that regenerates high-quality, durable tissue.
To find out more about the Hy2Care procedure and what makes it so revolutionary, click on the following video (12:43 min). A link to download a complete transcript of the interview is also provided below.
SmartTRAK: Hi, this is David Shepard with SmartTRAK. And I'm here with Leo Smit, the CEO for Hy2Care. Thank you for taking the time.
Leo Smit: Pleasure.
Excellent. So, if you could, tell me a little bit about your technology and your interest in getting into the cartilage space.
LS: Sure. Well, first, maybe a little bit about Hy2Care, we are a Dutch spin-off from the University of Twente. The group of Professor Marcel Karperien, he is a decades-old, experienced professor in the field of osteoarthritis and cartilage research. He came up together with a bunch of his co-workers with a new technology to repair cartilage. And that's a really unique technique. It's a hydrogel platform. It's a platform that is based on what we call joint mimicking composition, joint mimicking polymers. We use dextran and hyaluronic acid in a somewhat modified way and then make them... Allow them to be cross-linked during the surgery.
So, what we do is we take...
Want to learn more about Hy2Care and its unique hydrogel platform that addresses focal cartilage defects? Click the button below to download and read the complete transcript of our interview with Leo Smit, CEO of Hy2Care, conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.